113 related articles for article (PubMed ID: 24728500)
1. Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition.
Tanabe S; Aoyagi K; Yokozaki H; Sasaki H
Int J Oncol; 2014 Jun; 44(6):1955-70. PubMed ID: 24728500
[TBL] [Abstract][Full Text] [Related]
2. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
3. Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers.
Ohta H; Aoyagi K; Fukaya M; Danjoh I; Ohta A; Isohata N; Saeki N; Taniguchi H; Sakamoto H; Shimoda T; Tani T; Yoshida T; Sasaki H
Br J Cancer; 2009 Jan; 100(2):389-98. PubMed ID: 19107131
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition in gastric cancer (Review).
Katoh M
Int J Oncol; 2005 Dec; 27(6):1677-83. PubMed ID: 16273224
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription.
Yan HB; Wang XF; Zhang Q; Tang ZQ; Jiang YH; Fan HZ; Sun YH; Yang PY; Liu F
Carcinogenesis; 2014 Apr; 35(4):867-76. PubMed ID: 24293408
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
7. In silico analysis of stomach lineage specific gene set expression pattern in gastric cancer.
Pandi NS; Suganya S; Rajendran S
Biochem Biophys Res Commun; 2013 Oct; 439(4):539-46. PubMed ID: 24025679
[TBL] [Abstract][Full Text] [Related]
8. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
Kim TM; Ko YH; Ha SJ; Lee HH
BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
[TBL] [Abstract][Full Text] [Related]
9. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
Humar B; Guilford P
Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
[TBL] [Abstract][Full Text] [Related]
13. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
[TBL] [Abstract][Full Text] [Related]
14. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
[TBL] [Abstract][Full Text] [Related]
15. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis.
Sentani K; Oue N; Naito Y; Sakamoto N; Anami K; Oo HZ; Uraoka N; Aoyagi K; Sasaki H; Yasui W
Carcinogenesis; 2012 May; 33(5):1081-8. PubMed ID: 22411957
[TBL] [Abstract][Full Text] [Related]
17. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W
Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256
[TBL] [Abstract][Full Text] [Related]
18. The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer.
Kong U; Koo J; Choi K; Park J; Chang H
Hepatogastroenterology; 2004; 51(59):1519-23. PubMed ID: 15362791
[TBL] [Abstract][Full Text] [Related]
19. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
[TBL] [Abstract][Full Text] [Related]
20. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
